Alap: GLOGBE
Global X Genomics & Biotechnology Ucits ETF EUR | |
IE00BM8R0N95 | |
02.11.2021 | |
Equity | |
Részvény Sectors - Health Care | |
Global X Funds | |
Global X Management Company LLC | |
EUR | |
100 | |
5% |
1M | 3M | 6M | 9M | 1R | 3R p.a. | 5R p.a. | 7R p.a. | 10R p.a. | od vnizku p.a. | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Výkonnosť fondu | -1.83% | -6.87% | -5.64% | -4.35% | -15.88% | - | - | - | - | N/A | |
Priemerná výkonnosť (36 meraní) | - | - | - | - | - | ||||||
Volatilita od priemernej výkonnosti | - | - | - | - | - |
Long | Short | Net | |
---|---|---|---|
Részvény | 99.87% | 99.87% | |
Kötvény | |||
Other | |||
Pénz piac | 0.13% | 0.13% |
Aktíva | 61 mil. |
Počet akcíí | 41 |
Počet dlhopisov | 0 |
Priebež. popl. | 0.50 |
z toho Mng. popl. | 0.50 |
Výk. prémia | |
Trans. popl. |
Dividenda | |
Dividendový výnos | |
Rozhodný dátum | |
Frekvencia výplaty |
Giant | 0.00% |
Large | 7.80% |
Medium | 35.88% |
Small | 22.19% |
Micro | 34.00% |
P/E | 36.05% |
P/BV | 2.51% |
Healthcare | 99.87% |
Derivatives | 0.13 |
Výnos do splatnosti p.a. | |
Modifikovaná durácia |
United States | 91.34% |
Canada | |
Latin America | |
United Kingdom | |
Eurozone | 4.25% |
Europe - ex Euro | 3.69% |
Europe - Emerging | |
Africa | |
Middle East | |
Japan | 0.60% |
Australasia | |
Asia - Developed | |
Asia - Emerging | |
Emerging Market | |
Developed Country | 99.87% |
Not Classified |
Spoločnosť | Subsektor | Váha | Spoločnosť | Subsektor | Váha |
---|---|---|---|---|---|
Bio-Techne Corp | Healthcare | 4.8% | Moderna Inc | Healthcare | 4.79% |
Intellia Therapeutics Inc | Healthcare | 4.45% | Natera Inc | Healthcare | 4.3% |
Agilent Technologies Inc | Healthcare | 4.16% | Qiagen NV | Healthcare | 4.05% |
Arrowhead Pharmaceuticals Inc | Healthcare | 3.94% | Myriad Genetics Inc | Healthcare | 3.93% |
Sarepta Therapeutics Inc | Healthcare | 3.89% | BioNTech SE ADR | Healthcare | 3.88% |